Vascular and parenchymal Aβ deposition in the aging dog:: correlation with behavior

被引:106
作者
Colle, MA
Hauw, JJ
Crespeau, F
Uchihara, T
Akiyama, H
Checler, F
Pageat, P
Duykaerts, C [1 ]
机构
[1] Hop La Pitie Salpetriere, Lab Neuropathol R Escourolle, F-75651 Paris, France
[2] Hop La Pitie Salpetriere, Assoc Claude Bernard, Lab Neuropathol R Escourolle, F-75651 Paris 13, France
[3] Ecole Natl Vet Alfort, Serv Anatomopathol, Maisons Alfort, France
[4] Inst Psychiat, Tokyo, Japan
[5] Inst Pharmacol Mol & Cellulaire, Valbonne, France
[6] Pherosynthese, Apt, France
关键词
A beta peptide; canine; cognitive evaluation; Alzheimer's disease; senile plaques;
D O I
10.1016/S0197-4580(00)00113-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The behavior of 25 dogs was indirectly assessed by a formal questionnaire (evaluation of Age-Related Cognitive and Affective Disorders-ARCAD), filled out by the owner. The density of diffuse and vascular deposits was evaluated using four anti-A beta peptide antibodies, in four temporal areas. Parenchymal, diffuse deposits of A beta 42 peptide were found in all aged animals but one. They were Congo red negative and were not immunostained by the anti-A beta 40 antibody, contrary to the vascular deposits. The densities of vascular and parenchymal deposits were not correlated. The ARCAD score was correlated with age, density of A beta parenchymal and vascular deposits, and with the number of areas containing deposits (extension index). Multivariate analysis showed that the age and the extension index explained most of the variance. Congo red positivity (indicating that the A beta peptide has the characteristics of an amyloid substance) is limited in the dog to the vascular wall and is associated, as in man, with the deposition of the A beta 1-40 isoform. Parenchymal A beta deposition seems to be a common correlate of behavioral problems in aging dogs. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:695 / 704
页数:10
相关论文
共 49 条
[1]   The amino-terminally truncated forms of amyloid beta-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients [J].
Akiyama, H ;
Kondo, H ;
Mori, H ;
Kametani, F ;
Nishimura, T ;
Ikeda, K ;
Kato, M ;
McGeer, PL .
NEUROSCIENCE LETTERS, 1996, 219 (02) :115-118
[2]  
[Anonymous], 1979, STEREOLOGICAL METHOD
[3]   NEUROFIBRILLARY TANGLES BUT NOT SENILE PLAQUES PARALLEL DURATION AND SEVERITY OF ALZHEIMERS-DISEASE [J].
ARRIAGADA, PV ;
GROWDON, JH ;
HEDLEYWHYTE, ET ;
HYMAN, BT .
NEUROLOGY, 1992, 42 (03) :631-639
[4]   Characterization of new polyclonal antibodies specific for 40 and 42 amino acid long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases [J].
Barelli, HL ;
Lebeau, A ;
Vizzavona, J ;
Delaere, P ;
Chevallier, N ;
Drouot, C ;
Marambaud, P ;
Ancolio, K ;
Buxbaum, JD ;
Khorkova, O ;
Heroux, J ;
Sahasrabudhe, S ;
Martinez, J ;
Warter, JM ;
Mohr, M ;
Checler, F .
MOLECULAR MEDICINE, 1997, 3 (10) :695-707
[5]  
BOBIK M, 1994, SOC NEUROSCI, P172
[6]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[7]   NEUROFIBRILLARY CHANGES CONFINED TO THE ENTORHINAL REGION AND AN ABUNDANCE OF CORTICAL AMYLOID IN CASES OF PRESENILE AND SENILE DEMENTIA [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1990, 80 (05) :479-486
[8]   AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease [J].
BueeScherrer, V ;
Condamines, O ;
MourtonGilles, C ;
Jakes, R ;
Goedert, M ;
Pau, B ;
Delacourte, A .
MOLECULAR BRAIN RESEARCH, 1996, 39 (1-2) :79-88
[9]  
CHAPMAN BL, 1990, J AM VET MED ASSOC, V196, P944
[10]   FAMILIAL ALZHEIMERS-DISEASE ASSOCIATED WITH S182 CODON-286 MUTATION [J].
CHAPMAN, J ;
ASHEROV, A ;
WANG, NS ;
TREVES, TA ;
KORCZYN, AD ;
GOLDFARB, LG .
LANCET, 1995, 346 (8981) :1040-1040